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doi:10.1016/j.jtcvs.2005.08.048bjectives: Late graft occlusions after coronary artery bypass grafting have been
scribed to neointimal hyperplasia. Given the pivotal role of smooth muscle cells in
he pathogenesis of neointimal hyperplasia and the phenotypic heterogeneity of
mooth muscle cells across vessels, we hypothesized that differences in long-term
raft patency are at least partly related to differences in smooth muscle cell
roperties. The aim of the present study was to compare the vascular-wall remod-
ling of human internal thoracic artery, radial artery, and saphenous vein bypass
onduits.
ethods: We evaluated the intimal thickening of the human graft segments in organ
ultures (histopathology, morphometric, and immunofluorescence analyses) and
ssessed the properties of cultured smooth muscle cells isolated from these vessels
n terms of cell proliferation (tritiated thymidine incorporation), migration (modified
oyden chamber), and collagen synthesis (tritiated proline incorporation).
esults: The total vessel-wall growth index and the intimal growth index were
ignificantly higher for saphenous vein rings than for radial artery and internal
horacic artery rings. Immunofluorescence analyses showed predominant involve-
ent of smooth muscle cells in neointimal growth induced by organ culture of
aphenous vein rings. Cell proliferation was significantly higher in saphenous vein
mooth muscle cells than in radial artery smooth muscle cells and significantly
igher in radial artery smooth muscle cells than in internal thoracic artery smooth
uscle cells. Migration of smooth muscle cells from saphenous vein grafts was
ignificantly greater than from internal thoracic artery or radial artery grafts.
ollagen synthesis was similar in smooth muscle cells from internal thoracic artery,
adial artery, and saphenous vein grafts.
onclusions: Ex vivo vascular-wall remodeling and smooth muscle cell intrinsic
rowth and migratory properties are dissimilar between arterial and venous grafts
nd might shed light on reported angiographic patency rates of these grafts.
oronary heart disease is the most common cause of morbidity and mortality
in industrialized countries. Coronary artery bypass grafting (CABG) with a
combination of arterial and venous grafts is now a component of the
tandard treatment armamentarium for patients with coronary heart disease. CABG
educes both symptoms and mortality, particularly in patients with severe disease.
owever, its long-term benefits are dependent on continuing patency of the bypass
onduits.
The long-term patency of saphenous vein (SV) grafts is limited, and approxi-
ately half of these conduits undergo occlusion within 10 years.1 These late
cclusions have been ascribed to neointimal hyperplasia (NIH), with an accumula-
ion of smooth muscle cells (SMCs) and extracellular matrix in the graft intima. NIH
arrows the graft lumen and sets the scene for subsequent graft atherosclerosis.2
The Journal of Thoracic and Cardiovascular Surgery ● Volume 131, Number 3 651
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CSPCompared with SV grafts, internal thoracic artery (ITA)
rafts have yielded significantly better long-term results.3
his has prompted a search for other reliable arterial con-
uits. The radial artery (RA) was introduced by Carpentier
nd colleagues in 1973 as an alternative bypass conduit for
ABG. However, it was soon abandoned because of its high
ailure rate attributed to spasm of the denervated artery and
IH formation.4,5 Nonetheless, improved harvesting tech-
iques with avoidance of mechanical dilation, postoperative
asospasm prophylaxis, and appropriate grafting strategy
ave revived the radial artery as a conduit for coronary
evascularization.6 In fact, several groups have recently
eported better long-term clinical and angiographic results
han with SV grafts.7-10
Given the pivotal role of SMCs in the pathogenesis of
IH and the well-established phenotypic heterogeneity of
MCs across vessels,11 we hypothesized that differences in
ong-term graft patency are at least partly related to differ-
nces in SMC growth and migratory properties. To inves-
igate this hypothesis, we compared the remodeling of hu-
an ITA, RA, and SV bypass conduits using 2 approaches.
irst, we evaluated the intimal thickening of the ITA, RA,
nd SV segments in organ cultures. Second, we studied the
roperties of cultured SMCs isolated from ITAs, RAs, and
Vs in terms of cell proliferation, migration, and collagen
ynthesis.
ethods
atients
iscarded distal segments of ITAs, RAs, and SVs were ob-
ained from consecutive patients undergoing CABG. Premedi-
ation, anesthesia, and intraoperative heparinization were done
ccording to the usual protocol applied in our department of
ardiac surgery. Patients gave their informed consent to ex vivo
se of their blood vessel specimens. Material from 10 men and
women were sufficient for organ culture and cell culture. All
vessel types were not available for all patients. However, for
ach patient, at least 2 vessel types were available for each exper-
ment. Mean age was 67  13 years. Cardiovascular risk factors
Abbreviations and Acronyms
CABG  coronary artery bypass grafting
DMEM Dulbecco’s modified Eagle’s medium
FCS  fetal calf serum
ITA  internal thoracic artery
MMP Matrix metalloprotease
NIH  neointimal hyperplasia
PBS  phosphate-buffered saline
PDGF  platelet-derived growth factor
SMC  smooth muscle cell
SV  saphenous vein
TCA  trichloroacetic acidncluded diabetes (n  4), dyslipidemia (n  6), smoking (n  6), d
52 The Journal of Thoracic and Cardiovascular Surgery ● Marcfamily history of coronary artery disease (n  4), and hyperten-
ion (n  6).
rgan Culture, Histopathology, and Morphometric
nalysis
fter removal, the vessels were immediately immersed in Dul-
ecco’s modified Eagle’s medium (DMEM), placed at 4°C, and
ransferred to the laboratory within 24 hours. Two adjacent
ings 5 to 8 mm in length were dissected from each vessel. The
rst ring (R1) was immediately fixed without being cultured
nd served as the control. The second ring (R2) was fixed after
0 days of incubation in cell-culture flasks containing DMEM
upplemented with 10% fetal calf serum (FCS), 2 mmol/L
-glutamine, and antibiotics (100 U/mL penicillin and 0.1
g/mL streptomycin) at 37°C in a 5% CO2 humidified atmo-
phere. The medium was changed every 2 days. For micro-
copic studies, vessel rings were fixed in 4% formaldehyde
olution. Multiple transverse slides were processed in paraffin
ax. Sections 5 m in thickness were cut and stained with
ematoxylin and eosin, elastic stain, and orcein-picroindigo-
armine. The slides were examined with a Charge-Coupled
evice Iris camera (CDD Iris; Sony, Paris, France) coupled
ith an optical microscope (Laborlux, Wetzlar, Germany), and
mages were obtained with Perfect Image software (Clara Vi-
ion, Orsay, France). The total vessel wall area and the intimal
rea were measured on R1 and R2. The intima of ITAs and RAs
as defined as the zone between the endothelium and the
nternal elastic lamina, and the intima of SVs was defined as the
ayer of tissue between the endothelium and the media. The
essel-wall growth index was used to compare preculture sec-
ions of each vessel with corresponding cultured sections and
as computed as follows:
R2 total vessel wall area R1 total vessel wall area) ⁄
R1 total vessel wall area.
n addition, the intimal growth index was computed as follows:
(R2 intimal area R1 intimal area) ⁄ R1 intimal area.
mmunofluorescence Analyses
essel sections were obtained and embedded in paraffin. Paraffin
rom 5-m-thick sections was removed with xylene, and the sections
ere rehydrated through graded alcohol to water. Before labeling, the
ections were permeabilized for 10 minutes in phosphate-buff-
red saline (PBS) containing 0.1% Triton. The sections were
hen blocked with PBS containing 5% bovine serum albumin
or 1 hour. The sections were incubated for 1 hour at room
emperature with mouse anti--smooth muscle actin antibody
iluted 1:100, mouse anti-desmin antibody diluted 1:200, and
ouse anti-vimentin antibody diluted 1:100, which are specific
or SMCs.12 After washing, the sections were incubated for 1
our at room temperature with an anti-mouse (donkey) antibody
onjugated with Cy3 diluted 1:400. After washing, the sections
ere mounted and examined under a Zeiss Axiovert microscope
Zeiss, Le Pecq, France). Control experiments with secondary
ntibody without primary antibody were also performed to
etermine nonspecific binding.
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PMC Cultures
MCs were cultured from explants, as previously described.13
n brief, vessels were kept in DMEM at 4°C before their intimal
ell layer and residual adventitial tissue were stripped off. The
issected media of the vessels was then cut into small pieces
3-5 mm), which were transferred into cell-culture flasks. The
essel tissues were incubated in DMEM supplemented with
0% FCS, 2 mmol/L L-glutamine, and antibiotics (100 U/mL
enicillin and 0.1 mg/mL streptomycin) to allow the SMCs to
row out. After 2 weeks of incubation at 37°C and under a 5%
Figure 1. A, Structure and wall thickness of internal th
(SV) segments at baseline (day 0) and after 10 days of
taken after orcein-picro-indigo-carmine staining (bar 10
of each vessel after 10 days of culture. *P < .05 compared w
The Journal of ThoracicO2 humidified atmosphere, the SMCs collected in the culture
edium, and the vessel tissues were transferred into new cell-
ulture flasks. Cultured SMCs were used for experiments be-
ween passages 1 to 3.
easurement of SMC Proliferation
MCs in DMEM supplemented with 10% FCS were seeded in
4-well plates at a density of 5  104 cells per well and allowed
o adhere. The cells were then subjected to 48 hours of growth
rrest in medium containing only 0.2% FCS and incubated in
ic artery (ITA), radial artery (RA), and saphenous vein
ation in culture medium (day 10). The photograph was
). B, Vessel-wall growth index and intimal growth indexorac
incub
0mith values obtained with ITA and RA segments (n  7).
and Cardiovascular Surgery ● Volume 131, Number 3 653
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CSPMEM supplemented with 0.6 Ci/mL tritiated thymidine with
.5%, 5%, or 10% FCS. After incubation for 24 hours, the cells
ere washed twice with PBS, treated with ice-cold 10% trichlo-
oacetic acid (TCA), dissolved in 1N NaOH (0.5 mL/well), and
eutralized with 75 L of 12N HCl per well. The incorporated
adioactivity was then counted with a liquid scintillation counter.
ll experiments were run in 6 replicates.
MC Migration
MC migration was evaluated with a modified Boyden chamber. A
olycarbonate filter with an 8.0-m pore diameter (Costar, Cam-
ridge, United Kingdom) coated with 5 mg/L gelatin was used to
ivide the upper and lower well chambers. Cultured SMCs were
rypsinized and suspended in a concentration of 5  104 cells/mL
n culture medium containing 10% FCS. A volume of 0.2 mL of
uspended cells was placed in the upper chamber, and 0.5 mL of
he same culture medium was loaded in the lower chamber. After
4 hours of incubation (37°C at 5% CO2 in air) to allow cell
dhesion, the upper chamber medium was replaced with serum-
ree culture medium, and the lower chamber medium was replaced
ith culture medium containing FCS (0.5% or 5%). After 24 hours
f incubation, cells that had migrated to the bottom side of the filter
ere fixed with ethanol, stained with Diff Quick staining, and
ounted from 9 randomly chosen high-power (125) fields. All
xperiments were run in duplicate.
easurement of SMC Collagen Synthesis
ollagen synthesis was assessed on the basis of measurement of
ellular tritiated proline uptake, as previously described.14 Briefly,
MCs in DMEM supplemented with 10% FCS were seeded in
4-well plates at a density of 2  104 cells per well and allowed
o adhere. The cells were then subjected to 48 hours of growth
rrest in medium containing only 0.2% FCS and were then incu-
ated in DMEM supplemented with 1 Ci/mL tritiated proline
L-[4-3H(N)]-proline) with 0.5%, 5%, or 10% FCS. After incuba-
ion for 48 hours, the medium was removed, and ice-cold 10%
CA was added for 30 minutes at 4°C. After 2 rinses with cold
0% TCA, the acid-precipitable material was solubilized for 2
ours in 0.5 mL of 0.3N NaOH with 0.1% sodium dodecylsulfate
t 37°C. Incorporated radioactivity (in counts per minute) in the
emaining cell lysate was measured with a liquid scintillation
ounter. All experiments were run in 4 replicates.
hemicals
ritiated thymidine was from Amersham Pharmacia Biotech
Buckingham, United Kingdom). Tritiated proline was from NEN,
erkinElmer Life Sciences (Courtaboeuf, France). The primary
nd secondary antibodies used for immunofluorescence analyses
ere purchased from Dako (DakoCytomation S.A.S., Trappes,
rance) and Jackson Immunoresearch Inc (Cambridgeshire, United
ingdom), respectively. Antibiotics were from Laboratoires Dia-
ant (Paris, France) and Pharmacia (Saint-Quentin-en-Yvelines,
rance). FCS, DMEM, and PBS were from Invitrogen (Cergy
ontoise, France). We used the same lot of FCS for the entire
xperiment. Formaldehyde, xylene, triton, hematoxylin and eosin,
lastic stain, orcein-picroindigo-carmine, and gelatin were from
igma-Aldrich (Sigma-Aldrich Chimie, Lyon, France). n
54 The Journal of Thoracic and Cardiovascular Surgery ● Marctatistical Analysis
tatistical analysis was performed with SPSS Base 11.5 statistical
oftware (SPSS Inc, Chicago, Ill). All data are reported as means 
tandard error of the mean. Analysis of variance was used for
etween-group comparisons. When analysis of variance showed a
ignificant difference, the groups were compared with a Mann-
hitney nonparametric test.
esults
istopathology and Morphometric Analysis
igure 1 shows the organ culture results. The total vessel-
all growth index was significantly higher for SV rings than
or RA and ITA rings (47.9% 9.3% vs 11.6% 7.1% and
.4%  3.9%, respectively; P  .05 for both comparisons).
he intimal growth index was significantly higher for SV
ings than for RA and ITA rings (70.6%  28.1% vs 4.3% 
.0% and 7.6%  5.0%, respectively; P  .05 for both
omparisons). There was no significant difference between
TA and RA rings concerning both wall growth index
alues. Immunofluorescence analyses with -smooth mus-
le actin, desmin, and vimentin showed predominant in-
olvement of SMCs in neointimal growth induced by organ
ulture of SV rings (Figure 2).
igure 2. -Smooth muscle (SM) actin, desmin, and vimentin
mmunostaining in SV rings at baseline (day 0) and after 10 days
f culturing. Predominant -smooth muscle actin immunoreac-
ivity was noted both at baseline (day 0) and after 10 days of
eointimal growth.
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PMC Proliferation
CS stimulated proliferation of cultured SMCs from ITAs,
As, and SVs, as demonstrated by thymidine incorporation,
nd the effect was greatest with 10% FCS (Figure 3).
ritiated thymidine incorporation was significantly higher
n SV SMCs than in RA and ITA SMCs independent of FCS
oncentration (P  .05 for both comparisons). In addition,
ritiated thymidine incorporation in RA SMCs was signifi-
antly higher than in ITA SMCs with both 5% and 10%
CS (P  .05 for both comparisons).
MC Migration
MC migration was enhanced by FCS (Figure 4). Migration
f SMCs from SVs was significantly greater than that from
TAs or RAs (P .05 for both comparisons), whereas there
as no significant difference between SMCs from ITAs and
As.
MC Collagen Synthesis
CS stimulated tritiated OH-proline incorporation in cul-
ured SMCs from ITAs, RAs, and SVs, and the effect was
reatest with 10% FCS (Figure 5). At each level of FCS
timulation, tritiated OH-proline incorporation was similar
n SMCs from ITAs, RAs, and SVs.
iscussion
he present study evaluated vascular remodeling in human
TA, RA, and SV segments. Cultures showed significantly
reater NIH in SV rings than in ITA or RA rings. Cultured
MCs from SV grafts showed significantly greater prolif-
ration and migration than did arterial SMCs, whereas no
ifference was evidenced in collagen synthesis between
roups. Furthermore, SMCs from RAs exhibited signifi-
antly more proliferation than SMCs from ITAs.
NIH is a disease process that occurs early after grafting
nd affects both venous and arterial grafts.4 Although it can c
The Journal of Thoracice viewed as adaptive, it might also predispose the graft to
ater accelerated graft atherosclerosis.15 In the present study,
ulturing vessel rings with FCS induced NIH development
n all 3 types of vessels used for CABG. However, NIH was
ignificantly less pronounced in ITA and RA rings than in
V rings. These results are in accordance with previous
tudies of human bypass graft cultures showing greater NIH
everity in SV rings than in ITA rings16,17 and RA rings.17
able and colleagues17 have shown that organ culture of
TA and RA vascular rings for up to 14 days was not
ssociated with significant NIH. Vascular structure is
nown to influence NIH development: elastic arteries are
ess prone to NIH than are muscular arteries.18 The ITA has
mainly elastic media with few SMCs and a dense internal
lastic lamina with few fenestrations. This might be an
mportant barrier to SMC migration and might therefore
educe the development of NIH.1 In contrast, the highly
enestrated structure of the internal elastic lamina of SV
rafts and the thick and muscular media of RA grafts might
romote the development of NIH.18 However, there was no
ignificant difference in NIH development between RA and
TA rings in our study.
It is generally accepted that NIH involves proliferation of
MCs in the media of the graft. These proliferating cells
ubsequently migrate into the graft intima, where they un-
ergo further division and secrete extracellular matrix.19
ur organ culture model is in accordance with this patho-
enic concept, as demonstrated by the major presence of
MCs with immunofluorescence analyses. SMC prolifera-
ion and migration are complex processes regulated by multi-
le stimulatory and inhibitory influences. Differences in endo-
helial function, inherent properties of SMCs, or both, might
xplain our findings. However, although organ culture of
ascular rings maintains the anatomic relationships among
Figure 3. Stimulatory effect of increasing
concentrations of fetal calf serum (FCS) on
tritiated ([3H]) thymidine incorporation in cul-
tured smooth muscle cells from internal tho-
racic artery (ITA), radial artery (RA), and sa-
phenous vein (SV) rings. Values are presented
as means  standard error of the mean. *P <
.05 versus values obtained with ITA smooth
muscle cells under the same stimulation con-
ditions. §P < .05 versus values for RA smooth
muscle cells under the same stimulation con-
ditions. All experiments were run in 6 repli-
cates (n  5).ells of the vascular wall, several other variables that par-
and Cardiovascular Surgery ● Volume 131, Number 3 655
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CSP icipate in vivo are known to contribute to NIH (including
irculating cells, hemodynamic factors, flow, and size mis-
atch between the conduit and the recipient artery) and are
ot taken into account by this model. In addition, the re-
ponse to FCS might not represent the response seen in
ivo. Therefore our findings might not be extrapolated to the
linical setting.
The vascular endothelium has important regulatory
ffects on vascular-wall remodeling.20 Several endothe-
ium-derived mediators influence vascular SMC prolifer-
tion and migration. Thus, agents that increase SMC
yclic adenosine monophosphate concentrations (prosta-
landins E1 and I2) or cyclic guanosine monophosphate
oncentrations (nitric oxide) have been shown to inhibit
ascular SMC proliferation.21,22 ITAs release more prosta-
landin I2 and show greater nitric oxide–mediated endotheli-
m-dependent relaxation than SVs.1 Furthermore, He and
iu23 recently showed that basal and stimulated levels of
itric oxide release in human ITAs were significantly
reater than those seen in RAs. This lower capacity for
itric oxide release might contribute to the susceptibility of
As to perioperative vasospasm and might also influence
he long-term patency of RA grafts by greater SMC prolif-
ration and migration.
Alternatively, the differences in NIH across vessels
ould be related to differences in the inherent properties of
heir SMCs. Indeed, the phenotypic heterogeneity of vascu-
ar SMCs is now well established,11 and differences in
roliferation and migratory properties might translate into
issimilar propensities of blood vessels to exhibit NIH. The
igure 4. Smooth muscle cell (SMC) migration in response to
etal calf serum (FCS). *P < .05 versus values obtained with
nternal thoracic artery (ITA) SMCs and radial artery (RA) SMCs
nder the same stimulation conditions. All experiments were run
n duplicate (n  4). SV, Saphenous vein.esults of our cell-culture experiments suggest that SMCs m
56 The Journal of Thoracic and Cardiovascular Surgery ● Marcrom ITAs and RAs might be more resistant to mitogenic
timulation by FCS than those from SVs, suggesting a
reater propensity of SVs to enter a proliferative state. Yang
nd coworkers24 have shown that SMCs from SVs exhibit a
igher rate of serum-induced explant outgrowth and tritiated
hymidine incorporation compared with ITA SMCs. White
nd associates25 also evidenced a stronger tritiated thymi-
ine incorporation response to platelet-derived growth fac-
or (PDGF) in human SV-derived cells compared with that
een in ITA-derived cells. However, only limited data are
vailable on the proliferative capacity of SMCs from RAs
ompared with those from ITAs, SVs, or both. Del Rizzo
nd coworkers26 reported significantly less tritiated thymi-
ine uptake after stimulation with the PDGF-BB ho-
odimer in SMCs from ITAs and RAs compared with those
rom SVs. The same investigators found higher levels of
-fos expression (an oncoprotein regulating cell prolifera-
ion and differentiation) both constitutively and after
DGF-BB stimulation in SMCs from SVs. These data sug-
est that SV SMCs might have a greater propensity to enter
nto a proliferative state compared with SMCs from RAs or
TAs. In contrast to Del Rizzo and coworkers,26 we found
hat the proliferative response to FCS was significantly
tronger in RA SMCs than in ITA SMCs. However, as
oted above, this did not translate into increased NIH gen-
ration in RA rings compared with that seen in ITA rings.
onsidering the limited NIH production in arterial vascular
rafts,17 longer incubation periods (14 days) might be
ecessary to show significant differences between RA and
TA vascular rings. The increased inherent propensity of
A SMCs to proliferate might explain, in addition to the
reviously mentioned lower nitric oxide release, the higher
ncidence of NIH at harvesting27,28 and the consistently
ower long-term patency rates of RA grafts compared with
eft-sided ITA grafts in vivo.7
In addition to a diminished proliferative response of
rterial SMCs exposed to mitogens, we found significant
eductions in arterial SMC migration compared with that
een in SV SMCs. Matrix metalloproteases (MMPs) are
equired for NIH development, mainly because of their
ffects on SMC migration. Anstadt and associates29 recently
eported significantly reduced MMP-2 levels and activity in
TA grafts compared with that seen in SV grafts. Whether
MP expression in RA grafts is similar to that in ITA grafts
emains to be determined. However, we found no differ-
nces in migratory properties between RA SMCs and ITA
MCs in the present study.
We observed no significant differences in collagen syn-
hesis between SV-, ITA-, and RA-derived SMCs. This
bservation lies in contrast with the recent report by Wong
nd colleagues,30 who found that venous SMCs are more
edifferentiated and demonstrate increased proliferation,F
f
i
u
iigration, and synthetic capacity compared with arterial
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PMCs in serum-stimulated culture conditions. However,
hese authors used rabbit SMCs originating from carotid and
ugular veins, and SMC behavior might vary in different
ascular beds and species.
In conclusion, the human SV has a greater propensity
or NIH formation than arterial grafts, with increased
ntrinsic proliferative and migratory properties of venous
MCs. In contrast, we found no significant differences in
IH formation between ITA and RA grafts, despite sig-
ificantly increased proliferative properties of RA-
erived SMCs.
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